LTS Health and Formato Clinico assembled 5 panelists (from BioMérieux Iberia, Ortho Clinical Diagnostics, Cremer- Mafra Group, BD Life Sciences and COPAN Diagnostics, Inc.) to discuss the main systemic weakness of labs during the COVID-19 pandemic from the vendors' perspective.
CEO at LTS Health, Inc (Chicago, USA)
Director of Formato Clinico-Projetos em Medicina Diagnóstica. Biomédica de la Universidad de Santo Amaro de São Paulo- Brasil, Master en Microbiología de la Universidad de São Paulo-Brasil, Directora de Formato Clínico Brasil/Chile, autora de varios libros de microbiología clínica.